Redox Signaling in Cardiac Physiology and Pathology

被引:409
作者
Burgoyne, Joseph R. [2 ]
Mongue-Din, Heloise [1 ]
Eaton, Philip [2 ]
Shah, Ajay M. [1 ]
机构
[1] Kings Coll London, James Black Ctr, British Heart Fdn Ctr Excellence, Div Cardiovasc, London SE5 9NU, England
[2] St Thomas Hosp, Rayne Inst, London SE1 7EH, England
基金
英国惠康基金;
关键词
myocardial contractility; cardiac hypertrophy; NAD(P)H oxidase; oxidant signaling; MITOCHONDRIAL PERMEABILITY TRANSITION; MYOCARDIAL-ISCHEMIA-REPERFUSION; INDUCED CARDIOMYOCYTE HYPERTROPHY; NOX2-CONTAINING NADPH OXIDASE; HYPOXIA-INDUCIBLE FACTOR; HUMAN HEART-FAILURE; FACTOR-KAPPA-B; REACTIVE OXYGEN; ANGIOTENSIN-II; OXIDATIVE STRESS;
D O I
10.1161/CIRCRESAHA.111.255216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Redox signaling refers to the specific and usually reversible oxidation/reduction modification of molecules involved in cellular signaling pathways. In the heart, redox signaling regulates several physiological processes (eg, excitation-contraction coupling) and is involved in a wide variety of pathophysiological and homoeostatic or stress response pathways. Reactive oxygen species involved in cardiac redox signaling may derive from many sources, but NADPH oxidases, as dedicated sources of signaling reactive oxygen species, seem to be especially important. An increasing number of specific posttranslational oxidative modifications involved in cardiac redox signaling are being defined, along with the reactive oxygen species sources that are involved. Here, we review current knowledge on the molecular targets of signaling reactive oxygen species in cardiac cells and their involvement in cardiac physiopathology. Advances in this field may allow the development of targeted therapeutic strategies for conditions such as heart failure as opposed to the general antioxidant approaches that have failed to date. (Circ Res. 2012;111:1091-1106.)
引用
收藏
页码:1091 / 1106
页数:16
相关论文
共 159 条
[31]   Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease [J].
Cunnington, Colin ;
Van Assche, Tim ;
Shirodaria, Cheerag ;
Kylintireas, Ilias ;
Lindsay, Alistair C. ;
Lee, Justin M. ;
Antoniades, Charalambos ;
Margaritis, Marios ;
Lee, Regent ;
Cerrato, Ruha ;
Crabtree, Mark J. ;
Francis, Jane M. ;
Sayeed, Rana ;
Ratnatunga, Chandi ;
Pillai, Ravi ;
Choudhury, Robin P. ;
Neubauer, Stefan ;
Channon, Keith M. .
CIRCULATION, 2012, 125 (11) :1356-1366
[32]   Mitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy [J].
Dai, Dao-Fu ;
Chen, Tony ;
Szeto, Hazel ;
Nieves-Cintron, Madeline ;
Kutyavin, Vassily ;
Santana, Luis F. ;
Rabinovitch, Peter S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (01) :73-82
[33]   Mitochondrial Oxidative Stress Mediates Angiotensin II-Induced Cardiac Hypertrophy and Gαq Overexpression-Induced Heart Failure [J].
Dai, Dao-Fu ;
Johnson, Simon C. ;
Villarin, Jason J. ;
Chin, Michael T. ;
Nieves-Cintron, Madeline ;
Chen, Tony ;
Marcinek, David J. ;
Dorn, Gerald W., II ;
Kang, Y. James ;
Prolla, Tomas A. ;
Santana, Luis F. ;
Rabinovitch, Peter S. .
CIRCULATION RESEARCH, 2011, 108 (07) :837-U173
[34]   Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase γ Activity in Pressure Overload-Induced Cardiac Failure [J].
Damilano, Federico ;
Franco, Irene ;
Perrino, Cinzia ;
Schaefer, Katrin ;
Azzolino, Ornella ;
Carnevale, Daniela ;
Cifelli, Giuseppe ;
Carullo, Pierluigi ;
Ragona, Riccardo ;
Ghigo, Alessandra ;
Perino, Alessia ;
Lembo, Giuseppe ;
Hirsch, Emilio .
CIRCULATION, 2011, 123 (04) :391-399
[35]   Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction [J].
Doerries, Carola ;
Grote, Karsten ;
Hilfiker-Kleiner, Denise ;
Luchtefeld, Maren ;
Schaefer, Arnd ;
Holland, Steven M. ;
Sorrentino, Sajoscha ;
Manes, Costantina ;
Schieffer, Bernhard ;
Drexler, Helmut ;
Landmesser, Ulf .
CIRCULATION RESEARCH, 2007, 100 (06) :894-903
[36]   Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress [J].
Donath, S ;
Li, PF ;
Willenbockel, C ;
Al-Saadi, N ;
Gross, V ;
Willnow, T ;
Bader, M ;
Martin, U ;
Bauersachs, J ;
Wollert, KC ;
Dietz, R ;
von Harsdorf, R .
CIRCULATION, 2006, 113 (09) :1203-1212
[37]   Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling [J].
Dorn, Gerald W., II .
CARDIOVASCULAR RESEARCH, 2009, 81 (03) :465-473
[38]   Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets [J].
Drummond, Grant R. ;
Selemidis, Stavros ;
Griendling, Kathy K. ;
Sobey, Christopher G. .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) :453-471
[39]   Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion [J].
Eaton, P ;
Wright, N ;
Hearse, DJ ;
Shattock, MJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (11) :1549-1560
[40]   Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction -: A new action for an old drug? [J].
Engberding, N ;
Spiekermann, S ;
Schaefer, A ;
Heineke, A ;
Wiencke, A ;
Müller, M ;
Fuchs, M ;
Hilfiker-Kleiner, D ;
Hornig, B ;
Drexler, H ;
Landmesser, U .
CIRCULATION, 2004, 110 (15) :2175-2179